Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin N and Huminsulin Basal

Trial Profile

Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin N and Huminsulin Basal

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2017

At a glance

  • Drugs Insulin (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Julphar Gulf Pharmaceutical Industries
  • Most Recent Events

    • 24 Jul 2017 Planned End Date changed from 10 Feb 2017 to 30 Oct 2017.
    • 24 Jul 2017 Planned primary completion date changed from 1 Jan 2017 to 30 Oct 2017.
    • 24 Jul 2017 Status changed from completed to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top